Navigation Links
Drug-Resistant Staph a Widespread Threat
Date:10/16/2007

Dangerous infections occuring more often than previously believed, study finds

TUESDAY, Oct. 16 (HealthDay News) -- Potentially deadly, drug-resistant staph infections are more common, both in and out of hospitals, than experts once thought, a new study warns.

Methicillin-resistant Staphylococcus aureus (MRSA) infections are the top cause of skin and soft tissue infections among people in hospitals and can result in severe and even fatal disease. In fact, MRSA infections account for almost 19,000 deaths and more than 94,000 life-threatening illnesses each year in the United States.

"Invasive MRSA is an important public health problem," said lead researcher Dr. R. Monina Klevens, an epidemiologist at the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta. "We need to do a better job in preventing MRSA infections," she added.

In the study, Klevens' group used data from the Active Bacterial Core surveillance/Emerging Infections Program Network from July 2004 through December 2005 to estimate the incidence of MRSA infection in the United States.

The report is published in the Oct. 17 issue of the Journal of the American Medical Association.

The researchers uncovered 8,987 cases of invasive MRSA. Most of these (58.4 percent)) were found in community health care settings, 26.6 percent were in hospitals, 13.7 percent were infections not associated with health care facilities, and 1.3 percent could not be classified.

Klevens' team estimated the rate of invasive MRSA in 2005 at 31.8 per 100,000 persons, but that rate was higher for certain populations.

By age, rates of infection were highest for those 65 and older (almost 128 cases per 100,000). Blacks were much more likely than whites to become infected, at 66.5 cases per 100,000 versus about 28 per 100,000, respectively. Men had more cases (37.5 per 100,000) than women (26.3 per 100,000). The lowest rate was fo
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New UCSD Program to Fight Drug-Resistant Bacteria
2. Stem cells help in the understanding of drug-resistant, recurrent tumors
3. Finally, The First Ever Treatment for Drug-Resistant HIV
4. Research Leads to First Treatment for Drug-Resistant HIV
5. Latest Weapon in Battle against Drug-Resistant Bacteria
6. Misuse Of Anti-Microbial Drugs Have Given Rise To Multidrug-resistant TB Strains
7. A New Test to Detect Drug-resistant HIV Strains
8. STIs Significantly Increase Risk of Drug-resistant HIV Transmission
9. Drug-resistant Form of Plague Identified
10. WHO Cautions Against Spread of Drug-resistant Tuberculosis.
11. Warning Over Drug-resistant Diseases in EU
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)NEW ORLEANS, Dec. 5 There have been significant scientific advances in the field of blood cancers, and leading experts continue to gain a better understanding of how certain diseases progress in orde
(Date:12/5/2009)WASHINGTON, Dec. 5 ,, What: Cuts for a Cause ,, Why: To make a difference in the fight against cancer and other terminal illnesses affecting children. All proceeds from each hair service given
(Date:12/5/2009)CAPE TOWN, South Africa, December 5 The first Football,for Hope Centre in Khayelitsha in the outskirts of Cape Town opened its doors,today (5 December 2009). FIFA President Joseph S. Blatter was join
(Date:12/5/2009)--In Youngest Babies, This Type of Blood Cancer Is Most Challenging-- ,, PHILADELPHIA and NEW ORLEANS, Dec. 5 Pediatric oncologists have identified specific genes, dubbed partner genes, that fuse w
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9
...tists present the first proof that simple exposure...n cold. So, if your mother always warned you to...s she may have had a point. Scientists say the...rd Journal of Family Practice, an international sc...
... a breakthrough in infectious disease research, sc... Kawasaki disease, the most common cause of acquir... // Their study findings appear in the Novemb...inally described, but, until now, none has been id...
...ries called the sickness by the Italian phrase 'ma...-bearing zephyrs wafting from swamps. These d...s. // And they say ill winds are buffeting their a...of deaths are rising, infections are rising,' said...
...ictim to heart disease increased if the infant die...external factors. "The risk of premature cardiovas... syndrome, //especially when the fetus is adversel...factor for cardiovascular disease." Dr. Ray ...
...ef ministers of India's northeastern states are ex...AIDS in a political commitment to combat the disea... region. A daylong conclave on tackling the ...is also scheduled to attend. The meeting is e...
... licensed therapists do is no laughing matter. Th... The first 49 laughing therapists recently pa... make patients laugh to improve their immune syste...A doctor herself, Takayanagi has prescribed laught...
Other Medicine News:Health News:Scientist Affirm Mom’s Advice - Keep Yourself Wrapped Up To Avoid Cold 2Health News:Possible Viral Cause Of Kawasaki Disease Identified 2Health News:Malaria Vaccine May Be 10 Years Away 2Health News:Malaria Vaccine May Be 10 Years Away 3Health News:North-Eastern Leaders Of India Meet To Discuss HIV Problems 2Health News:Are You Ill? Have A Hard Laugh! 2
(Date:12/4/2009)WINSTON-SALEM, N.C., Dec. 4 A new, $2.8 million, four-year federal grant will support researchers at the University of Pittsburgh School of Medicine and their collaborators at Wake Forest University
(Date:12/4/2009)WASHINGTON, Dec. 4 A simple, inexpensive computer tool that measures volume changes in the size of suspicious nodules in the lungs picked up by a CT scanner can rule out non-cancerous ones with almos
(Date:12/4/2009)INDIANAPOLIS, Dec. 4 The U.S. Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes
Breaking Medicine Technology:NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 2NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 3European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7BIO key 28R 29 International to Exhibit at Oracle 28R 29 OpenWorld 10306 1BIO key 28R 29 International to Exhibit at Oracle 28R 29 OpenWorld 10306 2BIO key 28R 29 International to Exhibit at Oracle 28R 29 OpenWorld 10306 3Ford and Labor Leaders Join Forces with March of Dimes 59191 1Ford and Labor Leaders Join Forces with March of Dimes 59191 2OncoGenex Pharmaceuticals CEO Named Canadas Pacific Ernst 26amp 3B Youngs Entrepreneur Of The Year 28R 29 in the Health Sciences Category 14403 1OncoGenex Pharmaceuticals CEO Named Canadas Pacific Ernst 26amp 3B Youngs Entrepreneur Of The Year 28R 29 in the Health Sciences Category 14403 2OncoGenex Pharmaceuticals CEO Named Canadas Pacific Ernst 26amp 3B Youngs Entrepreneur Of The Year 28R 29 in the Health Sciences Category 14403 3
...lif., June 2 Jazz,Pharmaceuticals, Inc. (Nasdaq: ...n the first of two Phase III pivotal clinical tria...fibromyalgia., "Completion of enrollment in this ...expect to report top line results from this trial ...M.D., Chief Executive Officer., The JZP-6 Phase I...
...nd EMERYVILLE, Calif., June 2 ,Bayer HealthCare Ph...,(Nasdaq: ONXX ) today announced the presentation...ls in the development program for Nexavar(R),(sora...ung, thyroid,gastric and ovarian cancers. Nexavar ...r the treatment of patients with unresectable live...
Other Medicine Technology:Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia 2Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia 3New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 2New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 3New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 4New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 5New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 6
Finntip Filter Tips, 10ul
...e safety precautions must be taken to anticipate t...ioactive, highly toxic, or infectious sample mater...ng the contamination risk caused by foreign DNA (e...lter have an integrated filter made of pure hydrop...
Avant E-Z Rack Premium Low Binding Pipet Tips
RNase-free Tips, 1000 l size
Medicine Products: